Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma-Reference-Cited by-同舟云学术

Efficacy and tolerance of pegaspargase, gemcitabine and oxaliplatin with sandwiched radiotherapy in the treatment of newly-diagnosed extranodal nature killer (NK)/T cell lymphoma

Published:2016-08 Issue: Volume:47 Page:26-31
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Jing Xiao-mei^ORCID,Zhang Zhi-hui,Wu Ping,Zhang Shi-chuan,Ren Yuan-rong,Xiong Zhu-juan,Wei Wen,Luo Lei,Li Li

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference23 articles.

1. Variable clinical presentations of nasal and Waldeyer ring natural killer/T-cell lymphoma;Li;Clin. Cancer Res.,2009

2. The clinical study of extranodal natural killer cell lymphoma, nasal type;Gui;Med. Oncol.,2011

3. Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK/T-Cell Lymphoma: consortium for Improving Survival of Lymphoma study;Kim;J. Clin. Oncol.,2009

4. Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index;Chim;Blood,2004

5. How I treat NK/T-cell lymphomas;Tse;Blood,2013

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fifty‐Nine‐Year‐Old Male Patient Presenting With Ulcerating Palatal Lesions;Arthritis Care & Research;2024-05-15

2. Few and far between: clinical management of rare extranodal subtypes of mature T-cell and NK-cell lymphomas;Haematologica;2023-11-21

3. Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?;Frontiers in Oncology;2023-07-17

4. Inhibition of extranodal NK/T-cell lymphoma by Chiauranib through an AIF-dependent pathway and its synergy with L-asparaginase;Cell Death & Disease;2023-05-09

5. Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase–Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma;JAMA Oncology;2022-07-01